Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 12.25
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 0
  • Beta: 0.83

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
27-Jan-16 Panmure Gordon Buy 16.50p - 79.00p Reiteration
14-Oct-15 Panmure Gordon Buy 22.75p - 79.00p Reiteration
06-Oct-15 Panmure Gordon Buy 23.50p - 79.00p Reiteration
09-Jul-15 Panmure Gordon Buy 27.25p 79.00p 79.00p Reiteration
02-Jun-15 Panmure Gordon Buy - 79.00p 79.00p Reiteration
18-May-15 Panmure Gordon Buy - - 79.00p Reiteration
24-Mar-15 Panmure Gordon Buy - 79.00p 79.00p Reiteration
12-Jan-15 Panmure Gordon Buy - 79.00p 79.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

SCLP Market Data

Currency UK Pounds
Share Price 12.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 12.25
52 Week Low 7.50
Volume 0
Shares Issued 1,037.78m
Beta 0.83

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

SCLP Dividends

No dividends found

Trades for 15-Jan-2026

Time Volume / Share Price
10:01 2,500 @ 11.75p
09:41 3,207 @ 12.10p
09:32 174 @ 11.50p
09:32 164 @ 12.20p
09:30 16,678 @ 11.92p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page